The latest closing stock price for Karyopharm Therapeutics as of June 20, 2025 is 4.38.
An investor who bought $1,000 worth of Karyopharm Therapeutics stock at the IPO in 2013 would have $-982 today, roughly -1 times their original investment - a -28.39% compound annual growth rate over 12 years.
The all-time high Karyopharm Therapeutics stock closing price was 706.80 on June 13, 2014.
The Karyopharm Therapeutics 52-week high stock price is 17.39, which is 297% above the current share price.
The Karyopharm Therapeutics 52-week low stock price is 3.51, which is 19.9% below the current share price.
The average Karyopharm Therapeutics stock price for the last 52 weeks is 9.77.
An investor who bought $1,000 worth of Karyopharm Therapeutics stock at the IPO in 2013 would have $-982 today, roughly -1 times their original investment - a -28.39% compound annual growth rate over 12 years.
The all-time high Karyopharm Therapeutics stock closing price was 706.80 on June 13, 2014.
The Karyopharm Therapeutics 52-week high stock price is 17.39, which is 297% above the current share price.
The Karyopharm Therapeutics 52-week low stock price is 3.51, which is 19.9% below the current share price.
The average Karyopharm Therapeutics stock price for the last 52 weeks is 9.77.